Utilizing a nomogram, we predicted the prognostic impact of high CSPG4 expression on patients with BLCA over the next one, three, and five years, revealing a poorer prognosis for those with high CSPG4 expression (Figure 7H). The gene discussed is CSPG4; the disease is bladder transitional cell carcinoma.